Zai Lab Ltd SEC filings ZLAB
Zai Lab Ltd has 739 filings in SEC EDGAR's recent list, going back to May 30, 2017. Its latest annual report, Form ARS, was filed on Apr 28, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEFA14A | Additional proxy material | Apr 28, 2026 | — |
| DEF 14A | Proxy statement | Apr 28, 2026 | Jun 17, 2026 |
| PRE 14A | Preliminary proxy statement | Apr 17, 2026 | Jun 17, 2026 |
| DEFA14A | Additional proxy material | Apr 29, 2025 | — |
| DEF 14A | Proxy statement | Apr 29, 2025 | Jun 18, 2025 |
| PRE 14A | Preliminary proxy statement | Apr 18, 2025 | Jun 18, 2025 |
| DEFA14A | Additional proxy material | Apr 29, 2024 | — |
| DEF 14A | Proxy statement | Apr 29, 2024 | Jun 18, 2024 |
| PRE 14A | Preliminary proxy statement | Apr 19, 2024 | Jun 18, 2024 |
| DEF 14A | Proxy statement | Apr 28, 2023 | — |
| PRE 14A | Preliminary proxy statement | Apr 18, 2023 | — |
| DEFA14A | Additional proxy material | May 20, 2022 | — |
| DEFA14A | Additional proxy material | May 2, 2022 | — |
| DEF 14A | Proxy statement | May 2, 2022 | Jun 22, 2022 |
| PRE 14A | Preliminary proxy statement | Apr 22, 2022 | Jun 22, 2022 |
| DEFA14A | Additional proxy material | Mar 23, 2022 | — |
| DEF 14A | Proxy statement | Feb 28, 2022 | Mar 28, 2022 |
| PRE 14A | Preliminary proxy statement | Feb 11, 2022 | Mar 28, 2022 |
| DEFA14A | Additional proxy material | Apr 30, 2021 | — |
| DEF 14A | Proxy statement | Apr 30, 2021 | Jun 24, 2021 |
| PRE 14A | Preliminary proxy statement | Apr 14, 2021 | Jun 24, 2021 |
Showing 21 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ZLAB (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Cayman Islands
- Headquarters
- Shanghai
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1704292
- Former names
- Zai Lab Ltd (until Nov 5, 2026)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.